AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
NA - Nord America 5.886
EU - Europa 5.781
AS - Asia 1.378
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 8
AF - Africa 2
Totale 13.077
Nazione #
US - Stati Uniti d'America 5.854
IE - Irlanda 1.590
SE - Svezia 1.350
IT - Italia 989
CN - Cina 924
DE - Germania 527
UA - Ucraina 481
SG - Singapore 303
FI - Finlandia 272
GB - Regno Unito 175
PL - Polonia 131
FR - Francia 100
IN - India 98
BE - Belgio 73
VN - Vietnam 24
AT - Austria 23
CZ - Repubblica Ceca 20
RU - Federazione Russa 20
CA - Canada 18
MX - Messico 14
NL - Olanda 14
IR - Iran 12
EU - Europa 8
CL - Cile 7
AU - Australia 5
TW - Taiwan 5
CO - Colombia 3
KR - Corea 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CH - Svizzera 2
GR - Grecia 2
IL - Israele 2
A1 - Anonimo 1
BR - Brasile 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
JP - Giappone 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
Totale 13.077
Città #
Dublin 1.589
Chandler 1.111
Jacksonville 1.058
Nyköping 838
Beijing 395
Ashburn 304
Messina 300
Princeton 299
Medford 274
Ann Arbor 243
Cambridge 243
Des Moines 209
Singapore 175
Dearborn 172
Warsaw 126
Boardman 125
Wilmington 79
Jinan 77
Shenyang 73
New York 68
San Mateo 66
Brussels 65
Woodbridge 63
Lancaster 60
Nanjing 48
Hyderabad 46
Bremen 45
Los Angeles 45
Rome 42
Munich 38
Tianjin 37
Hebei 36
Pune 36
Ningbo 31
Zhengzhou 28
Taizhou 27
Caltagirone 26
Haikou 26
Helsinki 25
Dong Ket 24
Hangzhou 24
Norwalk 24
Seattle 24
Houston 22
Vienna 22
Falls Church 21
Brno 20
Palo Del Colle 18
Nürnberg 17
Catania 16
Washington 16
Augusta 15
Guangzhou 15
Milan 15
Ottawa 15
Auburn Hills 12
Fuzhou 12
Nanchang 12
Mascali 11
Taiyuan 11
Changsha 10
Ardabil 9
Guadalupe 9
Leawood 9
Rovereto 8
Bari 7
Monmouth Junction 7
Waanrode 7
Catanzaro 6
Jiaxing 6
Taranto 6
Torino 6
Ciudad Benito Juárez 5
Gela 5
Genova 5
Lanzhou 5
Lappeenranta 5
London 5
Monopoli 5
Mumbai 5
Bologna 4
Chambéry 4
Fairfield 4
Hefei 4
Padova 4
Redwood City 4
San Jose 4
Amsterdam 3
Anaheim 3
Bogotá 3
Chaoyang 3
Clearwater 3
Clifton 3
Corleone 3
Cosenza 3
Florence 3
Fremont 3
Hanover 3
Kunming 3
Livorno 3
Totale 9.111
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 366
Severe rhabdomyolysis in a patient with “Heat Stroke” 193
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 127
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 108
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 95
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 86
Hippo signaling pathway is altered in Duchenne muscular dystrophy 85
miRNA regulation of Sirtuin-1 expression in human astrocytoma 84
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 83
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 78
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 78
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 77
null 76
Role of inflammation and oxidative stress mediators in gliomas. 74
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 74
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 73
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 73
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 72
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 72
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 72
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 72
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 71
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 71
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 71
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 70
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 69
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 68
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 68
null 67
Miopatie metaboliche 67
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 66
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 66
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 65
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 65
A Nouvel serum MicroRNA signature to screen ATTR 65
Effect of exercise on telomere length and telomere proteins expression in mdx mice 65
Pilot study of flavocoxid in ambulant DMD patients. 64
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 64
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 63
Modulazione della lunghezza telomerica nei diversi gradi di tumore astrogliale nell'uomo. 63
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 63
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 63
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 63
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 63
EFFECT OF TREATMENT WITH PDTC AND IRFI 042 ON STRENGTH AND FATIGUE IN MDX MICE 62
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 62
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 62
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 62
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 61
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 61
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 60
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 60
A cytochemical study of apoptosis in metabolic myopathies 60
Pilot study of flavocoxid in ambulant DMD patients. 60
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 59
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 59
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 59
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 59
RAGE, NF-kB and oxidative stress: role in FSHD pathogenesis. 58
Detection of αII-Spectrin and Breakdown Products in Humans After Severe Traumatic Brain Injury 58
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 58
Ruolo patogenetico dei microRNAs nelle calpainopatie 58
Expression of transglutaminase in myopathies 57
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 57
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification 57
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 56
Dystrophin gene and SHOX gene mutations in a child with Becker muscular dystrophy and short stature 55
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 55
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 55
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 55
Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency 54
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 54
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 54
Fatal R631C mutation is also present in the adult form of CPTII deficiency 54
Myoadenilate deaminase deficiency: clinical, histochemical and biochemical studies in primary and coincidental cases. 54
Calpain 3 deficiency in Quail Eater's disease 54
Analysis of lipid profile in lipid storage myopathy 54
Expression of transglutaminase in myopathies 53
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 53
Telomere length modulation in astroglial brain tumors 53
Severe rhabdomyolysis in a patient with “Heat Stroke” 53
ANT1 is reduced in sporadic inclusion body myositis. 53
Clinical hetrogeneity and molecular basis of myoadenilate deaminase deficiency 52
Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity 52
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 52
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 52
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 51
Valutazione dell'influenza del polimorfismo del gene multi-drug resistance 1 (MDR1) e dell'espressione della P-glycoprotein (P-GP) sul decorso clinico e sulla sensibilità al trattamento steroideo nella sindrome nefrosica (SN) 51
Human astroglial tumors: transglutaminase 2 and retinoblastoma protein expression 51
A life threatening case of β-enolase deficiency 51
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 51
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 51
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 51
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 51
Ruolo della proteolisi dell'alfa spectrina nei pazienti affetti da trauma cranico grave 50
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 50
Transglutaminase 2 and its short isoform expression in human astroglial brain tumors 50
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma 50
A case of vacuolar myopathy during the course of chronic hepatitis C. 49
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx. 49
Totale 6.720
Categoria #
all - tutte 57.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.537 0 0 0 142 18 193 246 208 54 305 328 43
2020/20211.839 202 27 377 93 221 154 54 178 88 253 115 77
2021/20221.859 14 232 31 72 97 27 141 84 35 237 238 651
2022/20234.537 374 388 233 326 352 432 73 259 1.922 17 109 52
2023/20241.218 90 188 77 95 122 226 39 79 12 96 28 166
2024/2025387 108 61 114 104 0 0 0 0 0 0 0 0
Totale 13.461